PL EN


Preferences help
enabled [disable] Abstract
Number of results
2016 | 27 | 107 | 81-90
Article title

Toxicological aspects of metal impurities in cosmetics

Content
Title variants
PL
Toksykologiczne aspekty zanieczyszczeń metalicznych w kosmetykach
Languages of publication
PL
Abstracts
EN
Heavy metal compounds are included in many cosmetics and dietary supplements. The most frequent metal contaminants of cosmetic products are mercury, lead, cadmium and arsenic. The contents of toxic metals in cosmetic products are mainly associated with the use of inadequately cleaned raw materials. Despite numerous inspections of the manufacturing process andkeeping the production in line with the principles of Good Manufacturing Practice (GMP), these elements are still found even in products of the best quality. Metals contaminate cosmetics as a result of production processes. Heavy metal toxicity is the result of prolonged exposure which causes the appearance of many side effects. The mechanism of toxicity is mainly related to the impairment of ATP and the change of protein synthesis in enzyme activity, by inducing free radicals. Metals interfere with, among others, the proper functioning of organs, neurotoxic effects, cause problems in learning and behavior, adversely affect the proper functioning of the immune system and adversely affect the developping fetus. Metals have the ability to accumulate in certain organs, primarily in the kidneys and the liver. The European Union does not regulate the limits of metal concentrations in detail, but there is a list of substances prohibited for use in cosmetics in all Member States
Publisher

Year
Volume
27
Issue
107
Pages
81-90
Physical description
Contributors
  • Department of Toxicology, Faculty of Pharmacy, Jagiellonian University, Medical College, Medyczna 9, PL 30-688 Kraków, a.moniczewski@cm-uj.krakow.pl
  • Department of Toxicology, Faculty of Pharmacy, Jagiellonian University, Medical College, Medyczna 9, PL 30-688 Kraków
  • Department of Toxicology, Faculty of Pharmacy, Jagiellonian University, Medical College, Medyczna 9, PL 30-688 Kraków
References
  • 1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council. November 30, 2009.
  • 2. Bocca, B.; Pino, A.; Alimonti, A.; Forte, G. Regul. Toxicol. Pharmacol. RTP 2014, 68, 447–467.
  • 3. Chan, T. Y. K. Clin. Toxicol. Phila. Pa 2011, 49, 886– 891.
  • 4. Olumide, Y. M.; Akinkugbe, A. O.; Altraide, D.; Mohammed, T.; Ahamefule, N.; Ayanlowo, S.; Onyekonwu, C.; Essen, N. Int. J. Dermatol. 2008, 47, 344–353.
  • 5. Stejskal, V.; Hudecek, R.; Stejskal, J.; Sterzl, I. Neuro Endocrinol. Lett. 2006, 27 Suppl 1, 7–16.
  • 6. Zukiewicz-Sobczak, W. A.; Adamczuk, P.; Wróblewska, P.; Zwoliński, J.; ChmielewskaBadora, J.; Krasowska, E.; Galińska, E. M.; Cholewa, G.; Piątek, J.; Koźlik, J. Postępy Dermatol. Alergol. 2013, 30, 307–310.
  • 7. WHO, World Health Organization, 2011. Mercury in skin lightening products. Public Health and Environment, World Health Organization, Geneva, Switzerland.
  • 8. Copan, L.; Fowles, J.; Barreau, T.; McGee, N. Int. J. Environ. Res. Public. Health 2015, 12, 10943–10954.
  • 9. Park, J.-D.; Zheng, W. J. Prev. Med. Pub. Health 2012, 45, 344–352.
  • 10. Hu, Z.-M.; Zhou, Q.; Lei, T.-C.; Ding, S.-F.; Xu, S.-Z. J. Dermatol. Sci. 2009, 55, 179–184.
  • 11. Peregrino, C. P.; Moreno, M. V.; Miranda, S. V.; Rubio, A. D.; Leal, L. O. Int. J. Environ. Res. Public. Health 2011, 8, 2516–2523.
  • 12. Gbetoh, M. H.; Amyot, M. Environ. Res. 2016, 150, 403–410.
  • 13. Baum, C. R. Clin. Pediatr. Emerg. Med. 2012, 13, 324–330.
  • 14. Axelrad, D. A.; Bellinger, D. C.; Ryan, L. M.; Woodruff, T. J. Environ. Health Perspect. 2007, 115, 609–615.
  • 15. Al-Saleh, I. Int. J. Hyg. Environ. Health 2016, 219, 468–474.
  • 16. Misterska, M.; Walkowiak, H.; Silny, W.; Czarnecka-Operacz, M.; Żaba, R. Adv. Dermatol. Allergol. Dermatol. Alergol. 2010, XXVII, 504–510.
  • 17. Miller, S.; Pallan, S.; Gangji, A. S.; Lukic, D.; Clase, C. M. Am. J. Kidney Dis. Off. J. Natl. Kidney Found. 2013, 62, 135–138.
  • 18. Washam, C. Environ. Health Perspect. 2011, 119, A80–A81.
  • 19. Jaishankar, M.; Tseten, T.; Anbalagan, N.; Mathew, B. B.; Beeregowda, K. N. Interdiscip. Toxicol. 2014, 7, 60–72.
  • 20. Flora, G.; Gupta, D.; Tiwari, A. Interdiscip. Toxicol. 2012, 5, 47–58.
  • 21. Dobrakowski, M.; Kiełtucki, J.; Wyparło-Wszelaki, M.; Kasperczyk, S. Med. Śr. - Environ. Med. 2013, 16, 42–46.
  • 22. WHO | Lead poisoning and health http://www.who. int/mediacentre/factsheets/fs379/en/ (accessed Nov 23, 2016).
  • 23. Mason, L. H.; Harp, J. P.; Han, D. Y. BioMed Res. Int. 2014, 2014, 1–8.
  • 24. Tchounwou, P. B.; Yedjou, C. G.; Patlolla, A. K.; Sutton, D. J. EXS 2012, 101, 133–164.
  • 25. Agency for Toxic Substances and Disease Registry (ATSDR). (2010)- Toxic Substances - Lead https:// www.atsdr.cdc.gov/substances/toxsubstance.asp?toxid=22 (accessed Nov 25, 2016).
  • 26. Wani, A. L.; Ara, A.; Usmani, J. A. Interdiscip. Toxicol. 2015, 8.
  • 27. World Health Organization. 2010.
  • 28. Horton, L. M.; Mortensen, M. E.; Iossifova, Y.; Wald, M. M.; Burgess, P. Int. J. Pediatr. 2013, 2013, 1–13.
  • 29. Kim, H.-C.; Jang, T.-W.; Chae, H.-J.; Choi, W.-J.; Ha, M.-N.; Ye, B.-J.; Kim, B.-G.; Jeon, M.-J.; Kim, S.-Y.; Hong, Y.-S. Ann. Occup. Environ. Med. 2015, 27.
  • 30. D’Souza, H. S.; Menezes, G.; Venkatesh, T. Indian J. Clin. Biochem. 2003, 18, 154–160.
  • 31. US EPA, O. Learn about Lead https://www.epa.gov/ lead/learn-about-lead (accessed Nov 23, 2016).
  • 32. Al-Saleh, I.; Al-Enazi, S.; Shinwari, N. Regul. Toxicol. Pharmacol. RTP 2009, 54, 105–113.
  • 33. Al-Dayel, O.; Hefne, J.; Al-Ajyan, T. Orient J Chem 2011, 27, 01-11.
  • 34. Zakaria, A.; Ho, Y. B. Regul. Toxicol. Pharmacol. 2015, 73, 191–195.
  • 35. Nutrition, C. for F. S. and A. Products - Lipstick & Lead: Questions & Answers http://www.fda.gov/ cosmetics/productsingredients/products/ucm137224. htm#analyses (accessed Nov 25, 2016).
  • 36. Nourmoradi, H.; Foroghi, M.; Farhadkhani, M.; Vahid Dastjerdi, M.; Nourmoradi, H.; Foroghi, M.; Farhadkhani, M.; Vahid Dastjerdi, M. J. Environ. Public Health J. Environ. Public Health 2013, 2013, 2013, 1–5.
  • 37. Piccinini, P.; Piecha, M.; Torrent, S. F. J. Pharm. Biomed. Anal. 2013, 76, 225–233.
  • 38. Uddin, R.; Huda, N. H. Oman Med. J. 2011, 26, 207.
  • 39. Ratnaike, R. N. Postgrad. Med. J. 2003, 79, 391–396.
  • 40. Kumar, S.; Diwan, S.; Dekate, M.; Goyal, S. Our Dermatol. Online 2013, 4, 382–382.
  • 41. Singh, A. P.; Goel, R. K.; Kaur, T. Toxicol. Int. 2011, 18, 87–93.
  • 42. Shen, S.; Li, X.-F.; Cullen, W. R.; Weinfeld, M.; Le, X. C. Chem. Rev. 2013, 113, 7769–7792.
  • 43. Zhao, F.; Severson, P.; Pacheco, S.; Futscher, B. W.; Klimecki, W. T. Toxicol. Appl. Pharmacol. 2013, 271, 72–77.
  • 44. Bizoń, A.; Andrzejewska, A.; Milnerowicz, H. Med. Śr. - Environ. Med. 2013, 16, 47–54.
  • 45. Salama, A. K. Environ. Monit. Assess. 2016, 188, 553.
  • 46. Sainio, E. L.; Jolanki, R.; Hakala, E.; Kanerva, L. Contact Dermatitis 2000, 42, 5–10.
  • 47. Sneyers, L.; Verheyen, L.; Vermaercke, P.; Bruggeman, M. J. Radioanal. Nucl. Chem. 2009, 281, 259–263.
  • 48. IARC, International Agency for esearch on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Arsenic, Metals, Fibres and Dusts; Vol. Volume 100C.
  • 49. Chauhan, A. S.; Bhadauria, R.; Singh, A. K.; Lodhi, S. S.; Chaturvedi, D. K.; Tomar, V. S. J. Chem. Pharm. Res. 2010, 2, 92–97.
  • 50. Ziarati, P.; Moghimi, S.; Arbabi-Bidgoli, S.; Qomi, M. Int. J. Chem. Eng. Appl. 2012, 450–452.
  • 51. Hepp, N. M.; Mindak, W. R.; Gasper, J. W.; Thompson, C. B.; Barrows, J. N. J. Cosmet. Sci. 2014, 65, 125–145.
  • 52. Czeczot, H.; Majewska, M. Farm. Pol. 2010, 66, 243–250.
  • 53. Nnorom, I. C.; Igwe, J. C.; Oji-Nnorom, C. G. Afr. J. Biotechnol. 2005, 4, 1133–1138.
  • 54. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 100C. Cadmium and cadmium compounds; No. 100C; International Agency for Research on Cancer, 2012.
  • 55. Ma’or, Z. ’evi; Halicz, L.; Portugal-Cohen, M.; Russo, M. Z.; Robino, F.; Vanhaecke, T.; Rogiers, V. Regul. Toxicol. Pharmacol. 2015, 73, 797–801.
  • 56. Orisakwe, O. E.; Otaraku, J. O. Sci. World J. 2013, 2013, 1–7.
  • 57. Sipahi, H.; Charehsaz, M.; Güngör, Z.; Erdem, O.; Soykut, B.; Akay, C.; Aydin, A. J. Cosmet. Sci. 2015, 66, 313–323.
  • 58. Raj, S.; Jose, S.; Sumod, U. S.; Sabitha, M. J. Pharm. Bioallied Sci. 2012, 4, 186–193.
  • 59. Wright, P. F. Med. J. Aust. 2016, 204, 369–370.
  • 60. Fröhlich, E.; Roblegg, E. Toxicology 2012, 291, 10–17.
  • 61. Guix, M.; Carbonell, C.; Comenge, J. Contrib. Sci. 2008, No. 4, 213–217.
  • 62. Government of Canada, H. C. Guidance on Heavy Metal Impurities in Cosmetics [Health
  • Canada, 2012] http://www.hc-sc.gc.ca/cps-spc/ pubs/indust/heavy_metals-metaux_lourds/index-eng.php#f17 (accessed Jul 18, 2016).
  • 63. Commissioner, Office of the Federal Food, Drug, and Cosmetic Act (FD&C Act) http://www.fda. gov/regulatoryinformation/legislation/federalfooddrugandcosmeticactfdcact/default.htm (accessed Nov 27, 2016).
  • 64. ICCR Working Group on Traces. 2011.
  • 65. Branch, L. S. Consolidated federal laws of canada, Food and Drugs Act http://laws-lois.justice.gc.ca/ eng/acts/f-27/page-2.html#h-7 (accessed Nov 21, 2016). 66. Government of India. The Drugs and Cosmetics Rules, 1945 https://indiankanoon.org/doc/ 16293633/ (accessed Nov 27, 2016).
Document Type
undetermined
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-b7003103-d00c-4a9e-a66d-cf156f805704
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.